Medicines & Medical Devices

The thesis

Own businesses that develop and sell prescription medicines, vaccines and medical devices, rather than suppliers dependent on AI infrastructure spending. Drugmakers and medical-device shares have shown resilience in the supplied return data, making this a timely diversification from technology weakness. Established commercial franchises anchor the basket, while vaccine and obesity pipelines add growth potential; clinical setbacks, reimbursement pressure and demanding expectations remain risks.